Stay updated on CAR-T for CD33+ AML Clinical Trial
Sign up to get notified when there's something new on the CAR-T for CD33+ AML Clinical Trial page.

Latest updates to the CAR-T for CD33+ AML Clinical Trial page
- Check6 days agoChange DetectedA banner announces NIH website updates and explains that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check13 days agoChange DetectedThe revision number in the footer changed from v3.7.1 to v3.7.2 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study content, replacing the navigation and study details with an error screen. This blocks access to the trial information on the page.SummaryDifference20%

- Check62 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6 on the page. This indicates a minor update to the page's version history rather than a substantive change to content or functionality.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page moved from an error state to a full study details view, presenting the overview, eligibility criteria, design, outcomes, and contacts, along with added links and related terms.SummaryDifference59%

Stay in the know with updates to CAR-T for CD33+ AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAR-T for CD33+ AML Clinical Trial page.